Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.37 CHF | +0.81% | +1.14% | +10.02% |
May. 16 | Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15 | DP |
May. 16 | Novartis: presents results of tender offer for MorphoSysy | CF |
Sales 2024 * | 48.92B 44.46B | Sales 2025 * | 50.86B 46.21B | Capitalization | 210B 191B |
---|---|---|---|---|---|
Net income 2024 * | 10.42B 9.47B | Net income 2025 * | 11.92B 10.83B | EV / Sales 2024 * | 4.54 x |
Net Debt 2024 * | 12.44B 11.3B | Net Debt 2025 * | 11.34B 10.31B | EV / Sales 2025 * | 4.35 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
17.2
x | Employees | 76,057 |
Yield 2024 * |
3.51% | Yield 2025 * |
3.64% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +0.81% | ||
1 week | +1.14% | ||
Current month | +4.85% | ||
1 month | +10.47% | ||
3 months | +5.57% | ||
6 months | +11.02% | ||
Current year | +10.02% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 17 M€ | +7.73% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 93.37 | +0.81% | 3,439,522 |
24-05-16 | 92.62 | -0.73% | 2,832,960 |
24-05-15 | 93.3 | -0.20% | 2,511,921 |
24-05-14 | 93.49 | +0.45% | 2,742,580 |
24-05-13 | 93.07 | +0.81% | 3,892,615 |
Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.02% | 210B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+8.49% | 168B | |
-0.52% | 162B |
- Stock Market
- Equities
- NOVN Stock